Metabolic complications of organophosphate and carbamate poisoning

A M Saadeh1

  • 1Department of Internal Medicine, Faculty of Medicine, Jordan University of Science & Technology, Irbid. abdallah.saadeh@yahoo.com

Tropical Doctor
|July 11, 2001
PubMed

Insights

This study details the metabolic complications in 84 patients with acute organophosphate and carbamate poisoning. It highlights the underreported metabolic issues, especially in carbamate poisoning cases.

Area of Science:

  • Toxicology
  • Clinical Medicine
  • Biochemistry

Background:

  • Acute organophosphate (OP) and carbamate poisoning are well-documented clinically.
  • Previous research focused on cardiac, neurological, and respiratory complications.
  • Metabolic aspects, particularly in carbamate poisoning, remain under-explored.

Purpose of the Study:

  • To describe the metabolic complications associated with acute poisoning from organophosphate and carbamate compounds.
  • To shed light on the less-studied metabolic sequelae of carbamate poisoning.

Main Methods:

  • Retrospective analysis of 84 adult patients diagnosed with acute OP or carbamate poisoning.
  • Clinical data collection focusing on metabolic disturbances.

Main Results:

  • Detailed description of observed metabolic complications in the patient cohort.
  • Identification of specific metabolic alterations linked to carbamate exposure.

Conclusions:

  • Acute OP and carbamate poisoning present significant metabolic challenges.
  • Further research into the metabolic pathophysiology of carbamate poisoning is warranted.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...